About Exo Imaging
Exo Imaging is a leading healthcare AI company dedicated to revolutionizing medical imaging by making high-performance ultrasound accessible and intelligent at the point of care. Their core offering is an integrated ecosystem built around the handheld Exo Iris device, which leverages advanced silicon-based hardware and AI to deliver diagnostic-grade imaging across various clinical settings. This system provides real-time insights for critical assessments, including cardiac function (e.g., LVEF estimation, detection of heart failure indicators), lung pathologies (e.g., B-lines, effusions, consolidations), and fluid management (e.g., IVC collapsibility, bladder volume).
For physicians, Exo’s technology aims to simplify complex ultrasound procedures and enhance diagnostic confidence. The platform incorporates AI-powered features like SweepAI for guided scanning, which assists users in acquiring optimal images, and FDA-cleared AI applications for automated image interpretation. Complementing the hardware, the Exo Works software streamlines clinical workflows by centralizing image storage, automating documentation, and facilitating quality assurance and regulatory compliance, thereby improving efficiency and revenue capture for POCUS programs.
Exo is also committed to POCUS education and training, offering resources to support clinicians in adopting and achieving competency with handheld ultrasound. By combining miniaturized, high-quality imaging with intuitive AI and workflow solutions, Exo empowers healthcare professionals to make rapid, informed decisions at the bedside, ultimately improving patient outcomes and expanding the reach of advanced diagnostics.
Focus Areas
Business Intelligence
| Key Investors | RA Capital Management, BlackRock, Sands Capital, Avidity Partners, Pura Vida Investments, Intel Capital, Applied Ventures, Bold Capital Partners, Creative Ventures, Longevity Vision Fund, Magnetar Capital, Nautilus Venture Partners, OSF Healthcare, Rising Tide, Sony Innovation Fund, TDK Ventures, Fiscus Ventures, Reimagined Ventures, Qubit Health Capital, Samsung |
| Partnerships | Wellstar MCG Health, Samsung Medison, Sana Kliniken AG, Henry Ford Health |
| Acquisitions | Medo AI (acquired July 2022) |
| Technology | Proprietary Piezoelectric Micromachined Ultrasonic Transducers (pMUT) technology, silicon-based hardware, AI operating directly on device (Exo Iris), cloud-based workflow software (Exo Works), edge computing (AI operates without internet) |
| FDA Clearances | 14 cleared products (estimated) |
What Physicians Need to Know
Exo Imaging's integrated ecosystem, featuring the Exo Iris handheld device, real-time on-device AI (SweepAI), and the Exo Works workflow solution, significantly streamlines point-of-care ultrasound for physicians. The proprietary pMUT-based silicon technology ensures high-quality imaging in a portable format, while the FDA-cleared AI provides immediate, objective, and reproducible diagnostic insights, reducing operator dependence and the learning curve for POCUS. Exo U further supports education, making POCUS adoption easier. This comprehensive approach aims to provide immediate answers at the point of care, reduce administrative burden, and enhance diagnostic confidence, ultimately improving patient outcomes and increasing access to medical imaging.
Exo Works is designed to be device-agnostic and can integrate with most pre-existing healthcare devices and software, including common EMR and hospital PACS systems. This ensures seamless connectivity and data flow within existing clinical workflows, centralizing image storage, documentation, and billing.
What the Web Says
Exo Imaging is a company focused on modernizing medical imaging with its handheld ultrasound platform, Exo Iris, and AI-powered software, Exo Works. The company generally receives positive feedback for its innovative technology, ease of use, and commitment to improving patient outcomes through affordable and accessible medical imaging. However, some employer reviews indicate concerns regarding work-life balance, pay, and management.
Overall: MixedStrengths
- High-performance imaging with patented silicon technology and real-time AI.
- Compact, cost-effective, and easy-to-use handheld ultrasound system (Exo Iris).
- Intuitive workflow software (Exo Works) for efficient documentation and exam review.
- AI features like auto ejection fraction calculation and real-time recognition of imaging landmarks.
- Commitment to affordable and accessible medical imaging.
- Positive feedback on product design and responsiveness to user needs.
Limitations
- Some employer reviews cite poor work-life balance.
- Concerns about pay and benefits from employees.
- Negative feedback on management and an unstable work environment from some employees.
- Exo Iris only works with newer iPhone models (12 or newer) or the newest iPad.
- Exo Iris may overheat in hot environments.
- Image resolution, while good, may be a noticeable downgrade compared to standing ultrasound units for highly specialized procedures.
Based on reviews from: G2, Glassdoor, Capterra, Indeed.com, Reddit, ICE Magazine, AuntMinnie, Suresult, YouTube, App Store
Last updated: 2026-07-18
Videos
News, demos, and interviews about Exo Imaging.
Videos load interactively. If none appear, search YouTube for Exo Imaging →
Press & Coverage
Investors
Who's funded Exo Imaging.
Comparisons
For physicians considering a handheld ultrasound system with integrated AI, the Butterfly iQ/iQ+ and Exo Imaging’s AI Platform offer distinct advantages. The Butterfly iQ/iQ+ stands out for its ‘Ultrasound-on-Chip™’ technology, providing whole-body imaging with a single probe, making it highly versatile and potentially more cost-effective for general diagnostic needs. Its AI tools, such as Auto […]
For physicians evaluating handheld ultrasound systems with integrated AI, the Butterfly iQ3 and Exo Imaging’s AI Platform offer distinct advantages. The Butterfly iQ3 excels as a versatile, whole-body imaging solution, utilizing a single probe for over 20 clinical applications across a broad frequency range (1-12 MHz). Its AI tools, such as iQ Slice™ and Auto […]
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]